Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia

MLA

Jeanette Lundin, et al. “Lack of Association between the MDM2 Promoter Polymorphism SNP309 and Clinical Outcome in Chronic Lymphocytic Leukemia.” Leukemia Research, vol. 34, no. 3, Apr. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c920b9f603b04011809b8f8afe002170&authtype=sso&custid=ns315887.

APA

Jeanette Lundin, Rebeqa Gunnarsson, Mohd Arifin Kaderi, Eva Kimby, Nicola Cahill, Richard Rosenquist, Gunnar Juliusson, Norafiza Zainuddin, Jesper Jurlander, Mads Melbye, Mattias Jansson, Mahmoud Mansouri, Bengt Glimelius, & Anna Åleskog. (2009). Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia. Leukemia Research, 34(3).

Chicago

Jeanette Lundin, Rebeqa Gunnarsson, Mohd Arifin Kaderi, Eva Kimby, Nicola Cahill, Richard Rosenquist, Gunnar Juliusson, et al. 2009. “Lack of Association between the MDM2 Promoter Polymorphism SNP309 and Clinical Outcome in Chronic Lymphocytic Leukemia.” Leukemia Research 34 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c920b9f603b04011809b8f8afe002170&authtype=sso&custid=ns315887.